News

October 26th, 2021

Ubiquigent Extends and Expands Drug Discovery Collaboration with Bristol Myers Squibb

February 10th, 2021

Medivir licenses USP7 program to Ubiquigent

January 14th, 2021

Exploring the potential of DUBs and neglected tropical diseases

June 17th, 2020

Ubiquigent Continues Drug Discovery Collaboration with Bristol Myers Squibb

April 30th, 2020

COVID-19 Update: Ubiquigent fully operational

January 30th, 2020

DUBprofiler-Cell™ - target validation and compound-target engagement